New Delhi, July 1, 2025 — The Union Cabinet allocated One Lack Crore to strengthen science, technology, research, development, innovation, and design the electronics in India. India is emerging and entering in new era that will not only boost innovation and electronics manufacturing but also create more job opportunities. This initiative will pave the way for a self-reliant, self-innovative, and self-manufacturing India, positioning the country as a global technology leader & mark the position on world Map.
Which Industry / Sector will get benefit ? Sunrise Sector -Technology Driven, hyper demanding & Trending
Under the scheme, the “Anusandhan National Research Foundation” (ANRF) Executive Committee will play a key role in providing direction, guidelines, and defining the scope of projects in emerging and sunrise sectors. These sectors include green energy, agriculture, medical equipment, startups, innovation, robotics, and electronic design etc. The initiative aims to position India not just as an assembler but as a leading manufacturer and global supplier of innovative products. With this push, India is set to become a hub for high-end manufacturing and research-driven innovation, strengthening its position on the global technology and industrial map.
Electronics Industry
The electronics industry is growing rapidly across the globe, becoming an essential pillar of modern life. In today’s digital era, living without electronic devices and connectivity is nearly impossible, as they have transformed how we live, work, and communicate. The COVID-19 pandemic further accelerated this shift, making digital integration and reliance on electronic gadgets even more critical. As the world moves deeper into digitalization, the demand for innovative electronic products continues to rise, driving both production and economic growth. Although India had aimed to generate ₹400 billion in electronics revenue by 2025, the pandemic impacted these projections. However, the country now targets ₹300 billion in revenue by the end of 2025, reaffirming the sector’s role as a key engine for future growth.
Green Hydrogen Mission
India launched the National Green Hydrogen Mission on February 4, 2023, with the goal of establishing itself as a global hub for the production, export, and manufacturing of green hydrogen. Backed by a central government budget of INR 197.44 billion (US$2.37 billion), the mission focuses on promoting sustainable energy and reducing carbon emissions. A significant portion—US$2.1 billion—has been allocated to the Strategic Interventions for Green Hydrogen Transition (SIGHT) Programme, which offers incentives for green hydrogen production. The mission targets the production of 5 million metric tonnes per annum (MMTPA) of green hydrogen by 2030, positioning India at the forefront of the global green energy transition.
Electric Vehicle -EV
India’s electric mobility drive, supported by FAME II and 100% FDI, is unlocking major investment opportunities. With over 12,000 EV charging stations and a target to electrify 30% of vehicles by 2030, the sector is primed for growth. Rising two-wheeler EV registrations and the PLI Scheme for Advanced Chemistry Cells boost local battery manufacturing, lowering costs and improving competitiveness. Investors can tap into this green transition while benefiting from strong returns and contributing to a sustainable future.
Agro & Food Processing
Initiatives such as the Pradhan Mantri Kisan Sampada Yojana and liberalized FDI norms are unlocking attractive investment opportunities for both domestic and global investors in India’s agriculture and food processing (A&FP) sector. With a focus on boosting agricultural productivity and strengthening food processing capabilities, the sector offers immense potential for value addition and exports. The PLI Scheme for Food Processing further encourages investment in advanced infrastructure and technology. Supported by improved logistics and digital trading platforms, India’s A&FP sector is well-positioned for sustainable growth and global integration.
Healthcare & Pharmaceuticals
India’s healthcare and pharmaceutical sector stands at the intersection of innovation and growth, fuelled by rising healthcare expenditure, technological advancements, and strong government support. The medical technology (medtech) industry alone is projected to reach $50 billion by 2025, offering vast investment opportunities across diagnostics, devices, and digital health.
Strategic advantages such as skilled talent, cost efficiency, and the Make in India initiative are attracting manufacturers and investors alike. As India is poised to become the world’s third-largest economy by 2030–31, the healthcare and pharma sectors will be key drivers of this growth.
Biotechnology Sector
The biotechnology sector harnesses living organisms, biological systems, and innovative processes to create solutions in healthcare, agriculture, and environmental management. Spanning fields such as vaccine development, genetic modification, biofuels, and sustainable farming, biotechnology plays a crucial role in tackling global issues like disease control, food scarcity, and climate change.
India’s biotech industry is witnessing rapid expansion, fuelled by cutting-edge research and innovation across multiple domains. With a strong focus on medical breakthroughs, agricultural advancements, and eco-friendly technologies, India has emerged as a key player in the global biotech landscape. It currently ranks third in Asia for biotechnology capabilities and boasts a thriving startup ecosystem that continues to attract investment and foster innovation.
other sectors are Artificial intelligence, Petrochemical, Sports Industry, Auto Parts Industry, Capital Goods Production, Defence Manufacturing , Leather Goods Production, Banking, Fintech & Financial Services, Automobile Production and any more are under innovation.
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial, investment, or trading advice. All content, including stock analyses, market data, and opinions, is based on publicly available information believed to be accurate at the time of publication.
